Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-16

Clinical Trial Update: Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 trial investigating iLux for evaporative dry eye disease in contact lens wearers was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • iLux

Snippet

Sponsor: University of Waterloo | Conditions: Dry Eye | Phase 4 | Status: TERMINATED | Results posted: 2023-05-16